Treatment of High-Risk patients with ezetimibe plus simvastatin Co-Administration versus simvastatin alone to attain National Cholesterol Education Program Adult Treatment Panel III Low-Density lipoprotein cholesterol goals
- 15 June 2004
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 93 (12) , 1481-1486
- https://doi.org/10.1016/j.amjcard.2004.02.059
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Effect of Ezetimibe Coadministered With Atorvastatin in 628 Patients With Primary HypercholesterolemiaCirculation, 2003
- Efficacy and safety of ezetimibe coadministered with pravastatin in patients with primary hypercholesterolemia: a prospective, randomized, double-blind trialEuropean Heart Journal, 2003
- Efficacy and safety of ezetimibe coadministered with lovastatin in primary hypercholesterolemiaThe American Journal of Cardiology, 2003
- Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemiaJournal of the American College of Cardiology, 2002
- Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemiaThe American Journal of Cardiology, 2002
- Ezetimibe selectively inhibits intestinal cholesterol absorption in rodents in the presence and absence of exocrine pancreatic functionBritish Journal of Pharmacology, 2001
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Prevention of coronary heart disease in clinical practice: Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention1European Society of Cardiology, European Atherosclerosis Society, European Society of Hypertension, International Society of Behavioural Medicine, European Society of General Practice/Family Medicine, European Heart Network.1,2Published simultaneously in the European Heart Journal 1998;19:1434–1503 and the Journal of Hypertension (Summary only) 1998;16(10).2Atherosclerosis, 1998
- Apolipoprotein A-I and B Levels and the Risk of Ischemic Heart Disease During a Five-Year Follow-up of Men in the Que´bec Cardiovascular StudyCirculation, 1996
- Effects of Simvastatin and Cholestyramine in Familial and Nonfamilial HypercholesterolemiaArchives of internal medicine (1960), 1990